Browse Related Topics For:

Patents

2717
Patent Litigation
2059
Patent Infringement
1056
USPTO
878
SCOTUS
874
Inter Partes Review Proceedings
831
Patent-Eligible Subject Matter
830
Patent Trial and Appeal Board
704
Pharmaceutical Industry
563
Pharmaceutical Patents
500
America Invents Act
492
Claim Construction
417
Patent Applications
395
Prior Art
389
CLS Bank v Alice Corp
365
Patent Reform
341
Popular
331
Infringement
310
Appeals
251
Software
242
Obviousness
225
Biotechnology
221
Covered Business Method Patents
221
Trademarks
220
Generic Drugs
219
Myriad
215
DNA
212
Patent Trolls
208
Mayo v. Prometheus
207
Copyright
202
Post-Grant Review
201
Patent Invalidity
195
ANDA
194
Induced Infringement
189
ITC
180
Prescription Drugs
175
AMP v Myriad
172
FDA
168
Design Patent
161
EU
161
Section 101
149
FTC
149
Trade Secrets
140
Attorney's Fees
137
Discovery
133
Human Genes
128
Inventors
121
Hatch-Waxman
120
Covered Business Method Proceedings
118
Apple
117
Australia
114
Standard Essential Patents
111
Biosimilars
111
Octane Fitness v. ICON
111
Patent Ownership
110
Summary Judgment
109
Abstract Ideas
107
Patent-in-Suit
106
En Banc Review
105
Indefiniteness
105
License Agreements
103
First-to-File
102
Patent Royalties
98
Corporate Counsel
97
CLS Bank
97
Medical Devices
97
Technology
96
IP License
95
Alice Corporation
95
BPCIA
92
Young Lawyers
91
FRAND
89
Intellectual Property Litigation
88
Intellectual Property Protection
88
Nautilus Inc. v. Biosig Instruments
87
Genetic Materials
85
Computer-Related Inventions
85
Teva v Sandoz
84
Royalties
83
Inventions
83
Non-Practicing Entities
81
Expert Testimony
80
Federal Rules of Civil Procedure
80
Patent Term Adjustment
78
Evidence
78
Jurisdiction
78
Teva Pharmaceuticals
77
De Novo Standard of Review
77
Life Sciences
76
Direct Infringement
74
Standing
73
China
73
Sandoz
71
Damages
71
Licenses
69
Samsung
68
Microsoft
65
Clear Error Standard
65
Declaratory Judgments
65
Limelight v Akamai
65
Motion to Amend
64
Actavis Inc.
64
Innovation Act
64
Motion to Dismiss
64
Preliminary Injunctions
63
Cisco v CommilUSA
63
Highmark v. Allcare
63
Reverse Payment Settlement Agreements
63
Section 337
61
Akamai Technologies
60
FTC v Actavis
60
Google
59
Utility Patents
58
Amgen
58
Patent Prosecution
57
Good Faith
57
Motion To Stay
57
Patent Exhaustion
57
Sandoz v Amgen
56
Healthcare
56
Injunctions
55
Broadest Reasonable Interpretation Standard
55
First-to-Invent
55
Manufacturers
55
Novartis
53
Kimble v Marvel Enterprises
53
Proposed Legislation
52
Antitrust Litigation
51
Joinder
51
Patent Filings
51
Petition For Rehearing
50
Imports
49
Limelight Networks
48
Exceptional Case
48
Myriad-Mayo
47
Expert Witness
46
Cisco
46
Real Party in Interest
45
Apple v Samsung
45
Biologics
45
Risk Mitigation
45
Standard of Review
44
Guidance Update
44
Willful Infringement
43
DOJ
43
Medtronic
43
Startups
42
Estoppel
42
Pay-For-Delay
42
Settlement
41
Bilski
41
Copyright Infringement
41
Innovation
41
Inter Partes Reexamination
40
Motorola
39
EPO
39
Patent Assertion Entities
39
Reversal
39
Sequenom
38
Brulotte
38
European Court of Justice (ECJ)
38
Stare Decisis
37
Cuozzo Speed Technologies
37
Misappropriation
36
AstraZeneca
36
BRCA
36
Confidential Information
36
Genetically Engineered Seed
36
Patent Examinations
35
Apotex
35
Burden of Proof
35
Depositions
35
Mylan Pharmaceuticals
34
Means-Plus-Function
34
Sanctions
34
UK
34
Validity
33
Breach of Contract
33
Canada
33
Ex Partes Reexamination
33
Laches
33
Monsanto
33
Pfizer
32
Abuse of Process
32
Class Action
32
Patent Cooperation Treaty
32
Remand
31
Certiorari
31
Inequitable Conduct
31
Personal Jurisdiction
31
Pleading Standards
31
Product of Nature Doctrine
31
Sherman Act
30
Bowman v Monsanto
30
Hart-Scott-Rodino Act
30
Honest Belief Defense
30
Kappos
30
Pleadings
30
Preemption
30
Public Comment
30
Request for Continued Examination
30
Written Descriptions
29
Bad Faith
29
Disclosure Requirements
29
Japan
29
Safe Harbors
29
Software Developers
28
Arbitration
28
Competition
28
Diagnostic Method
28
Genetic Testing
28
Stem cells
27
Advertising
27
FDA Approval
27
Hague Agreement
27
Legislative Agendas
27
Limelight
27
Markman Hearing
27
Noninfringement
27
Notice Requirements
27
PATENT Act
27
Patent Terms
27
Software Patents
27
Unitary Patent
26
Eli Lilly
26
Gene Patenting
26
Statute of Limitations
26
Ultramercial v Hulu
26
Watson Pharmaceuticals
25
Attorney-Client Privilege
25
Fee-Shifting
25
Merck
25
Patent Portfolios
25
WIPO
24
Automotive Industry
24
Dismissals
24
Indirect Infringement
24
Injunctive Relief
24
Subject Matter Jurisdiction
24
Suprema
24
Vacated
23
ACLU
23
European Patent Office
23
Frivolous Lawsuits
23
Hedge Funds
23
Litigation Strategies
23
Mobile Devices
23
Patent Dance
23
Pending Legislation
23
Rule 11
23
Trade Dress
22
Brooks Furniture
22
Counterclaims
22
Doctrine of Equivalents
22
Internet
22
Lanham Act
22
Patent Owner Preliminary Response
21
Foreign Patent Applications
21
Oral Argument
21
Patent Prosecution Highway
21
Petrella v. MGM
21
RAND
21
Unified Patent Court
21
Universities
20
Australian Patent Office
20
Divided Infringement
20
Gilead Sciences
20
Interim Guidance
20
New Legislation
20
Smartphones
19
Amicus Briefs
19
Business Assets
19
CAFC
19
Chevron Deference
19
European Commission
19
Judicial Review
19
Orange Book
19
Reissue Patents
19
Unfair Competition
18
Comment Period
18
Contract Term
18
Cybersecurity
18
Data Protection
18
Definiteness
18
Diagnostic Tests
18
Functionality
18
Industrial Design
18
Interference Proceeding
18
Medtronic v Boston Scientific
18
Non-Disclosure Agreement
18
Proposed Amendments
18
Seeds
18
Venue
17
Acquisitions
17
Administrative Procedure Act
17
ALJ
17
Allergan Inc
17
Collateral Estoppel
17
Enforcement
17
Examiners
17
First Sale Doctrine
17
Foreign Investment
17
Par Pharmaceutical
17
Permanent Injunctions
17
Protective Orders
17
Trademark Litigation
17
Websites
16
Ambry
16
Antitrust Provisions
16
Article III
16
Attorney Malpractice
16
Biologics Price Competition and Innovation Act of 2009
16
Bristol-Myers Squibb
16
Clean Tech
16
Document Productions
16
Ford Motor
16
GlaxoSmithKline
16
Judgment on the Pleadings
16
Jury Verdicts
16
Monopolization
16
Motion for Summary Judgment
16
Motion to Compel
16
Motion To Strike
16
Oil & Gas
16
Personalized Medicine
16
Provisional Applications
16
Stays
16
Testimony
16
The Copyright Act
15
Additional Discovery
15
Auto Manufacturers
15
Barack Obama
15
Bayh-Dole Act
15
Disclosure
15
Filing Deadlines
15
Issue Preclusion
15
Mootness
15
Myriad v Ambry
15
Petition for Writ of Certiorari
15
Qualcomm
15
SEC
15
Trademark Infringement
15
Unfair or Deceptive Trade Practices
14
Brand
14
Cross Examination
14
Declaration
14
Enablement Inquiries
14
Entrepreneurs
14
Exclusion Orders
14
Fashion Industry
14
Federal Register
14
Final Judgment
14
First Amendment
14
Germany
14
IP Assignment Agreements
14
Joint Infringement
14
Lexmark
14
Miniauction
14
New Guidance
14
Nintendo
14
Takeda Pharmaceuticals
14
The Patent Box
14
Trademark Trial and Appeal Board
14
Trans-Pacific Partnership
14
Transfer of Venue
14
TRIPS Agreement
13
Abuse of Discretion
13
Abuse of Dominance
13
Anti-Competitive
13
Cancer
13
Cephalon
13
Customs
13
Derivation Proceeding
13
Disparagement
13
Due Process
13
eBay
13
False Advertising
13
Final Rules
13
Foreign Corporations
13
Forum Selection
13
Legal Perspectives
13
Marketing
13
Patent Expiration
13
Prior User
13
Proposed Regulation
13
Research and Development
13
Small Business
13
STRONG Patents Act
13
WTO
12
Allergan v Sandoz
12
Commercial Marketing
12
Contributory Infringement
12
Corporate Taxes
12
Enforcement Actions
12
Fees
12
Innovation Patent
12
Investigations
12
Irreparable Harm
12
JMOL
12
Jury Trial
12
Kirtsaeng v. John Wiley & Sons
12
Micro Entity Status
12
New Zealand
12
Nokia
12
On-Sale Bar
12
Plant Patents
12
Social Media
12
SSO
12
Tariff Act of 1930
12
Telecommunications
12
Treble Damages
12
Uniform Trade Secrets Acts
12
Venture Capital
11
Commercial Bankruptcy
11
Compliance
11
Counterfeiting
11
Cross-Border
11
Dispute Resolution
11
Due Diligence
11
Endo Pharmaceuticals
11
Energy Sector
11
Expiration Date
11
Facebook
11
Farms
11
Garmin International
11
Genentech
11
Generic
11
Gunn v Minton
11
IEEE
11
Interlocutory Appeals
11
Investors
11
Marvel Comics
11
Method Claims
11
Motions in Limine
11
Nanotechnology
11
Pre-GATT
11
SAP America Inc.
11
Sprint
11
Supplemental Evidence
11
Third-Party
11
Twombly/Iqbal Pleading Standard
11
Wireless Technology
10
Affirmative Defenses
10
Amazon
10
Ambiguous
10
Antitrust Investigations
10
Assignments
10
Biopharmaceutical
10
Daubert Standards
10
Dell
10
Divisional Applications
10
Domestic Industry Requirement
10
E-Commerce
10
Exports
10
FDCA
10
Federal Jurisdiction
10
Filing Fees
10
General Electric
10
Indemnification
10
iPhone
10
IPO
10
IPR
10
Legislative Committees
10
LG Electronics
10
Licensing Rules
10
Lost Profits
10
Mediation
10
Medical Research
10
Mergers
10
Order to Stay
10
Patent Fees
10
Patent Validity
10
Patentability Search
10
Petitions for Review
10
Prevailing Party
10
PTO
10
Supplemental Examination
10
Trademark Registration
10
Transparency
10
Versata
10
Writ of Mandamus
9
3-D Printing Technology
9
AbbVie
9
aBLA
9
AFCP
9
Assignment of Inventions
9
Barnes and Noble
9
Calculation of Damages
9
Chemicals
9
Claim Preclusion
9
Cloud Computing
9
Confidentiality Agreements
9
Covenant Not to Sue
9
Customs and Border Protection
9
DMCA
9
Duty of Candor
9
Electronics
9
Equitable Estoppel
9
Ericsson
9
Fair Use
9
FCPA
9
Federal Pilot Programs
9
Foreign Jurisdictions
9
Fraud
9
Fresenius
9
Hana Financial v Hana Bank
9
IBM
9
Intel
9
International Arbitration
9
International Litigation
9
JPO
9
Jury Awards
9
Licensing Rights
9
Likelihood of Confusion
9
Litigation Fees & Costs
9
Mobile Apps
9
Motion for Judgment
9
Motion for Sanctions
9
New Trial
9
Patent Amendments
9
Patent Law Treaty
9
Patent Oppositions
9
PHRMA
9
Presumption of Validity
9
Prometheus
9
Public Disclosure
9
Public Interest
9
Public Use
9
Right of Publicity
9
Roxane Laboratories
9
Rulemaking Process
9
Salesforce
9
Terminal Disclaimer
9
Transfers
8
Abbott Laboratories
8
Adobe
8
Affordable Care Act
8
Algorithms
8
Antitrust Violations
8
AOL
8
AT&T Mobility
8
B&B Hardware v Hargis Industries
8
Bayer
8
Cartels
8
Cease and Desist
8
Cybor Corp v FAS Technologies
8
DaimlerChrysler v Bauman
8
Data Collection
8
Demand Letter
8
Exclusions
8
Extraterritoriality Rules
8
Extrinsic Evidence
8
Federal Contractors
8
Food Manufacturers
8
Hospitals
8
Information Disclosure Statement
8
Italy
8
Joint Venture
8
JPMorgan Chase
8
Motion for Reconsideration
8
Premerger Notifications
8
Privity of Contract
8
Reasonable Certainty Standard
8
Registration
8
Res Judicata
8
Retailers
8
Rule-of-Reason Analysis
8
Settlement Agreements
8
SIPO
8
Sua Sponte
8
Subsidiaries
8
Supply Chain
8
Tacking
8
Technology Sector
8
Tortious Interference
8
Toyota
8
Twitter
8
USPTO Pilot Program
8
Wearable Technology
8
WildTangent v Ultramercial
8
Work Product Privilege
7
3D Printing
7
Amended Complaints
7
Anti-Dumping Duty
7
Anti-Monopoly
7
Applications
7
Clinical Trials
7
Commercial General Liability Policies
7
Contract Interpretation
7
Defend Trade Secrets Act (DTSA)
7
Dow Chemical
7
Draft Guidance
7
Employment Contract
7
Energy
7
Fair Market Value
7
Fashion Design
7
Fast Track Process
7
Filing Requirements
7
GMO
7
gTLD
7
Health Insurance
7
Hewlett-Packard
7
Holidays
7
Hulu
7
International Harmonization
7
Misrepresentation
7
MOFCOM
7
MPEP
7
Music
7
NIH
7
OECD
7
Oracle
7
OTDP
7
PLTIA
7
Preponderance of the Evidence
7
Printed Publications
7
Sanofi-Aventis
7
Scope of the Claim
7
Split of Authority
7
Spoliation
7
Subject Matter Experts
7
Suppliers
7
Symantec
7
Target
7
Tariffs
7
Tesla
7
The Clayton Act
7
Theft
7
Trade Agreements
7
USDA
7
Walker Process Claims
7
Wyeth
6
Airlines
6
Arbitration Agreements
6
Assignor Estoppel
6
Banks
6
Biofuel
6
Blackberry
6
Case Consolidation
6
Classen Immunotherapies
6
Comcast
6
Contempt
6
Coopertive Patent Classification System
6
Countervailing Duties
6
Cross-Licensing Agreement
6
Databases
6
Deadlines
6
Defense Strategies
6
Domain Names
6
eBay Test
6
Electronic Data Transmissions
6
Enhanced Penalties
6
European Patent Convention
6
False Claims Act (FCA)
6
Federal Question Jurisdiction
6
Federal Rules of Evidence
6
Fiduciary Duty
6
Financial Products
6
Foreign Sales
6
Forum Shopping
6
Forward Publishing
6
Grable Factors
6
Grace Period
6
Health Care Providers
6
Hospira
6
HTC
6
HTC America
6
Information Reports
6
Inherency
6
Intellectual Property Owners Association
6
Inventive Concept Test
6
Jazz Pharmaceuticals
6
Joint Inventors
6
Judge Rakoff
6
Jury Instructions
6
Labeling
6
Legal History
6
Mandamus Petitions
6
Memorandum of Guidance
6
Motion to Exclude
6
Multinationals
6
NAFTA
6
Nike
6
NLRB
6
Otsuka Pharmaceutical
6
Physicians
6
Price-Fixing
6
Putative Class Actions
6
Raising The Bar Act
6
Renewable Energy
6
Resales Agreements
6
RICO
6
Roslin
6
Rule 26
6
Rules of Civil Procedure
6
Russia
6
Service of Process
6
Sony
6
South Korea
6
Supplemental Information
6
Supplementary Protection Certificate
6
Technology Transfer Agreements
6
Telemedicine
6
Totality of Circumstances Test
6
Treatment Method Patents
6
USTR
6
UTSA
6
Video Games
6
Webinars
6
YouTube
5
Alien Tort Statute
5
Anti-SLAPP
5
Anticompetitive Agreements
5
Apportionment
5
Audits
5
Bifurcation
5
Biogen Idec
5
Board of Directors
5
Canon
5
Carnegie Mellon
5
Cease and Desist Orders
5
Cell Phones
5
Co-Ownership
5
Collaboration
5
Competition Act
5
Confidential Documents
5
Contract Disputes
5
Contract Terms
5
COPPA
5
Copyright Litigation
5
Creditors
5
Criminal Prosecution
5
Deceptive Intent
5
Defamation
5
Duty to Defend
5
Economic Espionage Act
5
Effective Filing Date
5
Elon Musk
5
Email
5
Emerging Growth Companies
5
End-Users
5
Entertainment Industry
5
Equitable Relief
5
Evidentiary Rulings
5
Exelixis
5
Failure To State A Claim
5
False Statements
5
Food Labeling
5
Forum
5
Free Speech
5
GAO
5
Garmin Factors
5
Highmark
5
Hiring & Firing
5
Honda
5
Honeywell International
5
Hotels.com
5
India
5
Information Technology
5
Insider Trading
5
Insurance Industry
5
International Searching Authority
5
IPEC
5
Japan Patent Office
5
Judges
5
Judgment As A Matter Of Law
5
Keurig Inc
5
Law Matters
5
Legal Costs
5
Malicious Prosecution
5
Motion to Transfer
5
Multidistrict Litigation
5
New Regulations
5
Noerr-Pennington Doctrine
5
Online Advertisements
5
Oracle v Google
5
Patent Agent Privilege
5
Patent Term Extensions
5
Penalties
5
Philips Electronics
5
Priority Date Cutoff
5
Privacy Laws
5
Privilege Waivers
5
Proctor & Gamble
5
Quanta
5
RanBaxy
5
Redskins
5
Restrictive Covenants
5
Reversible Error
5
Risk Assessment
5
SCA Hygiene
5
Scienter
5
Securities Fraud
5
Seventh Amendment
5
Shire Development v Watson
5
Solar Energy
5
Sonos
5
Source Code
5
Standard Setting Organizations
5
Strategic Enforcement Plan
5
Strategic Planning
5
Tax Incentives
5
Tax Reform
5
TD Ameritrade
5
The Patent Act
5
Toshiba
5
Trial de Novo
5
Trials
5
TROL Act
5
TSA
5
UCC
5
Unjust Enrichment
5
Use in Commerce
5
Waivers
5
Warner Chilcott
4
23andMe
4
ACIP
4
Adidas
4
Administrative Authority
4
Administrative Proceedings
4
Advertising Injury
4
Affidavits
4
Africa
4
AIPLA
4
Annual Reports
4
Antitrust Conspiracies
4
Antitrust Injuries
4
AT&T
4
Bed Bath & Beyond
4
Bitcoin
4
Boilerplate Language
4
Business Development
4
CAFA
4
Certifications
4
Claim Charts
4
Class Certification
4
Clear and Convincing Evidence
4
CMS
4
Coca Cola
4
Common-Interest Privilege
4
Compulsory Licenses
4
Computer Fraud and Abuse Act (CFAA)
4
Conflicts of Interest
4
Consent Decrees
4
Consent Order
4
Consumer Bankruptcy
4
Contract Drafting
4
Contract Negotiations
4
Copyright Office
4
Copyrights
4
Crowdfunding
4
Cyber Insurance
4
Daiichi Sankyo
4
DaimlerChrysler
4
DDR Holdings v Hotels.com
4
Determination on Remand
4
Digital Goods
4
Digital Health
4
Digital Media
4
Disclaimers
4
Discrimination
4
Document Requests
4
Double Patent
4
Elan Pharmaceuticals
4
Electric Vehicles
4
Employment Policies
4
Encryption
4
Energy Policy
4
ETSI
4
Ex Parte
4
Expatriates
4
Expedited Actions Process
4
Experimental Use Exception
4
Federal Rule 12(b)(6)
4
Financial Institutions
4
Financing
4
First Glance
4
Foreign Priority Applications
4
Foreign Subsidiaries
4
FTAIA
4
Gaming
4
Genuine Issue of Material Fact
4
Graham Factors
4
Graphical User Interface
4
Hoffman LaRoche
4
ICANN
4
Income Taxes
4
Indemnity Agreements
4
Insolvency
4
International Labor Laws
4
International Treaties
4
Internet Streaming
4
IP Litigation
4
Janssen Pharmaceuticals
4
Japan Airlines
4
Joint Enterprise Theory
4
Kessler Doctrine
4
KIPO
4
Kraft
4
Legislative Process
4
Liberty Mutual Insurance Company
4
Licensees
4
Lobbying
4
March-in
4
Mitsubishi
4
Mixed Motive Cases
4
Motion To Reconsider
4
Motion To Sever
4
Music Industry
4
Musical Instrument Patents
4
Native American Issues
4
Natural Products
4
New York Times
4
Nexium
4
Nexus
4
Non-Compete Agreements
4
NPRM
4
Nunc Pro Tunc
4
Obama Administration
4
Objection Procedures
4
Objectively Unreasonable Standard
4
Organic Seed Growers & Trade Assn
4
Patent Notice
4
Patent-Misuse
4
Pharmacies
4
Plant Variety Protection Act
4
Plastic Solar Cells
4
Prejudgment Interest
4
Prejudice
4
Principal Place of Business
4
Prioritized Examination
4
Private Right of Action
4
Professional Conferences
4
Progressive Casualty Insurance Company
4
Redaction
4
Remedies
4
Reporting Requirements
4
Reputational Injury
4
Reverse Payments
4
Right to a Jury
4
Sales
4
Scams
4
Section 271
4
Securities
4
Shareholder Litigation
4
SHIELD Act
4
Social Networks
4
Standard of Proof
4
T-Mobile
4
Termination
4
Trade Names
4
Trade Policy
4
Trade Relations
4
U.S. Commerce Department
4
Valuation
4
Verizon
4
Virtual Patent Marking
4
Wal-Mart
4
WARF
4
White Collar Crimes
4
Willful Misconduct
4
Witnesses
4
Work-For-Hire
4
World Intellectual Property Organisation
4
Zynga
3
510(k) RTA
3
ABC v Aereo
3
Abusive Discovery Strategies
3
Administrative Appeals
3
Admissibility
3
Aesthetic Functionality
3
Affirmative Action
3
Agency Deference
3
Agents
3
Aiding and Abetting
3
Already LLC
3
Alzheimer's
3
Amarin
3
Amended Regulation
3
American Airlines
3
Analogous Art
3
Anti-Bribery
3
Anti-Patent Trolls
3
Antitrust Division
3
Ariosa
3
Asia
3
Asset Protection
3
Asset Valuations
3
Attorney Generals
3
AU Optronics Corp
3
Banking Sector
3
Bankruptcy Code
3
BEPS
3
Best Practices
3
Big Data
3
Boston Scientific
3
Brazil
3
Broadcasting
3
Business Entities
3
Business Formation
3
Cadence Pharmaceuticals Inc.